STRATA Skin Sciences to Participate in Oppenheimer’s 29th Annual Healthcare Conference
Dr. Rafaeli’s participation will not be webcast, but the Company’s latest investor presentation will be available in the investor’s section of the Company’s website at www.strataskin.com.
The Company’s proprietary XTRAC® excimer laser delivers a highly targeted therapeutic beam of UVB light to treat psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma, diseases, which impact over 35 million patients in
STRATA’s unique business model leverages targeted Direct to Consumer (DTC) advertising to generate awareness and utilizes its in-house call center and insurance advocacy teams to increase volume for the Company’s partner dermatology clinics.
The XTRAC business has used this proven DTC model to grow its domestic dermatology partner network to over 740 clinics, with a worldwide installed base of over 2,000 devices. The Company is able to offer 90% of DTC patients an introduction to physicians prescribing a reimbursable solution, using XTRAC, within a 10 mile radius of their house. The Company is a leader in dermatology in-clinic business generation for its partners.
|Matthew Hill, Chief Financial Officer||Jeremy Feffer, Managing Director|
|STRATA Skin Sciences, Inc.||LifeSci Advisors, LLC|